Literature DB >> 9348116

Distribution of the secretory leucocyte proteinase inhibitor in human articular cartilage.

S Ohlsson1, B Tufvesson, A Polling, K Ohlsson.   

Abstract

The secretory leucocyte protease inhibitor, SLPI, is a low molecular weight inhibitor of proteases such as elastase and cathepsin G, which are released from leucocytes during phagocytosis. The purpose of this study was to show whether or not SLPI is produced in articular chondrocytes. In articular disorders, the protease-antiprotease balance is disturbed. For this reason it would be interesting to establish the source of SLPI. The presence of SLPI was demonstrated using immunohistochemistry and in situ hybridization, hence we conclude that SLPI is produced in the chondrocytes of human articular cartilage.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9348116     DOI: 10.1515/bchm.1997.378.9.1055

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  4 in total

1.  Nfib promotes chondrocyte proliferation and inhibits differentiation by mildly regulating Sox9 and its downstream genes.

Authors:  Daian Pan; Benxin Qian; Daqing Zhao; Baojin Yao
Journal:  Mol Biol Rep       Date:  2021-10-15       Impact factor: 2.316

2.  Increased expression of the secretory leukocyte proteinase inhibitor in Wegener's granulomatosis.

Authors:  S Ohlsson; R Falk; J J Yang; K Ohlsson; M Segelmark; J Wieslander
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

3.  Novel distribution of the secretory leucocyte proteinase inhibitor in kidney.

Authors:  S Ohlsson; I Ljungkrantz; K Ohlsson; M Segelmark; J Wieslander
Journal:  Mediators Inflamm       Date:  2001-12       Impact factor: 4.711

4.  Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis.

Authors:  X y Song; L Zeng; W Jin; J Thompson; D E Mizel; K Lei; R C Billinghurst; A R Poole; S M Wahl
Journal:  J Exp Med       Date:  1999-08-16       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.